Long intergenic non-protein coding RNA 1782 (LINC01782)

Long intergenic non-protein coding RNA 1782 (LINC01782) is a member of the long intergenic non-coding RNAs (lincRNAs)[1]. LincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap coding genes and generally do not encode proteins[3]. These RNAs are involved in diverse roles regulating gene expression, chromatin structure, and RNA stabilization, often with significant tissue specificity and through interactions with proteins or nucleic acids[3]. While many lincRNAs—including well-characterized examples—have documented biological and pathological functions, the specific biological role, disease association, or pharmacological targeting of LINC01782 has not been established in the current literature[1]. There is no evidence that LINC01782 is a therapeutic target, interacts with drugs, or is used as a biomarker based on the sources reviewed. Notes: - LINC01782 should not be confused with similarly named lincRNAs such as LINC00052, which do have documented roles in cancer[2]. Based on current evidence, LINC01782 itself appears not to have characterized disease associations. - The molecular family is “long intergenic non-coding RNA” and not a receptor, enzyme, transporter, or canonical drug target[1][3]. - No common alternative names are documented beyond the formal gene symbol LINC01782[1].

Other names

LINC01782